Skip to main content

Table 1 Baseline characteristics of CRC and mCRC patients

From: Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China

Characteristics

CRC patients

mCRC patients

(N = 8136)

(N = 3878)

Age at diagnosis, year

 Mean (SD)

59 (13)

57 (12)

 Median (IQR)

60 (50–68)

58 (49–66)

 Min - max

18–96

18–96

Age group, n (%)

 18–49

1883 (23%)

1075 (28%)

 50–59

2035 (25%)

1067 (28%)

 60+

4218 (52%)

1736 (45%)

Gender, n (%)

 Female

3233 (40%)

1472 (38%)

 Male

4903 (60%)

2406 (62%)

Department of practice, n (%)

 Internal medicine

7074 (87%)

3584 (92%)

 Surgery

1062 (13%)

294 (7.6%)

Hospital geographic region, n (%)

 North

489 (6%)

416 (11%)

 South

4972 (61%)

2258 (58%)

 East

533 (6.6%)

463 (12%)

 Midwest

2142 (26%)

741 (19%)

Primary tumor size at diagnosis, centimeters

 Missing, n (%)

2926 (36%)

2116 (55%)

 Mean (SD)

4.48 (2.05)

4.52 (2.09)

 Median (IQR)

4 (3–5.5)

4 (3–5.5)

Mutation status, n (%)

 KRAS MUT

794 (10%)

525 (14%)

 KRAS WT

1246 (15%)

805 (21%)

 Unknown

6096 (75%)

2548 (66%)

Primary tumor site at diagnosis, n (%)

 Left-sided

5751 (71%)

2659 (69%)

 Right-sided

1767 (22%)

879 (23%)

 Colorectal NOS

618 (7.6%)

340 (8.8%)

ECOG PS at diagnosis, n (%)

 Missing, n

2386

1470

 0

724 (12%)

429 (18%)

 1

4912 (86%)

1919 (80%)

 2

65 (1.1%)

51 (2.1%)

 3

11 (0.19%)

7 (0.29%)

 4

4 (0.07%)

2 (0.08%)

  1. Note: CRC colorectal cancer, mCRC metastatic colorectal cancer, SD standard deviation, IQR: interquartile range, min minimum, max maximum, MUT mutation, WT wild-type, NOS not otherwise specified, ECOG PS Eastern Cooperative Oncology Group Performance Status